Varenicline-fig1.jpg (Varenicline Fig1)
Varenicline Kit
Product Images NDC 59651-451
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 59651-451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label-principal Display Panel (1 mg Continuing Month Box Carton)
This is a medication guide for Varenicline tablets, each film-coated tablet contains 1.71 mg Varenicline tartrate equivalent to 1.01 mg Varenicline free base. The recommended dosage is one 1 mg tablet in the morning and one 1 mg tablet in the evening. It is important to refer to the accompanying Medication Guide for additional information. The tablets are to be stored at 20°C to 25°C (66°F to 77°F). Distributor details: Aurobindo Pharma USA, Inc. Made in India. NDC code: 59651-418-55. This is a continuing month box with 56 tablets for your next 4 weeks' supply. Pharmacists are advised to dispense the Medication Guide separately to each patient.*
Package Label-principal Display Panel (1 mg x 56 Tablet Continuing Pack)
Varenicline-fig2.jpg (Varenicline Fig2)
Varenicline-fig3.jpg (Varenicline Fig3)
This is a graph showing the Continuous Abstinence Rate during Nontreatment Follow-Up for individuals using Varenicline 1mg twice daily (BID) compared to those on placebo. The x-axis represents the nontreatment follow-up duration measured in weeks while the y-axis shows the continuous abstinence rate. The data points indicate the increase in abstinence rates over time for both Varenicline and Placebo users, demonstrating the effectiveness of Varenicline in promoting continuous abstinence from smoking.*
Figure 4 (Varenicline Fig4)
This text provides a structured plan to gradually reduce smoking over a period of 12 weeks. It suggests reducing the number of cigarettes smoked each day by specific fractions in each 4-week period until reaching zero cigarettes per day by the end of the 12 weeks. The plan encourages a step-by-step approach to quitting smoking.*
Figure 5 (Varenicline Fig5)
This is a treatment plan that involves taking white tablets (0.5 mg) daily for the first three days, then taking one white tablet (0.5 mg) daily on days 4 to 7 (one in the morning and one in the evening). From day 8 until the end of treatment, a light blue tablet (1 mg) should be taken twice daily, once in the morning and once in the evening. Follow the specified instructions for each day to complete the treatment regimen effectively.*
Package Label-principal Display Panel (0.5 mg Container Label (56 Tablets Bottle))
This text provides information about Varenicline tablets manufactured by Aurobindo Pharma USA, Inc. Each film-coated tablet contains 100.5 mg varenicline free base. The dosage and usage instructions are available in the accompanying prescribing information. The tablets should be stored at a temperature of 20°C to 25°C (68°F to 77°F). The medication should be dispensed in a tight, child-resistant packaging. Pharmacies are advised to dispense the Medication Guide provided separately to each patient. The text also mentions that the tablets are made in India.*
Package Label-principal Display Panel (0.5 mg and 1 mg Tablet Starting Month Box Carton)
This text contains information about Varenicline tablets, including the dosage and usage instructions for quitting smoking. It provides details on the recommended dosage for different days, storage conditions, and a note about child-resistant packaging. Aurobindo Pharma USA is mentioned as the distributor. The text also refers to the website for printing Medication Guides and includes the address for the distributor in New Jersey. Overall, it serves as a guide for patients starting a month-long Varenicline tablet treatment plan to aid in smoking cessation.*
Package Label-principal Display Panel (Starting Pack)
Package Label-principal Display Panel (1 mg Container Label (56 Tablets Bottle))
The text provides information about varenicline tablets distributed by Aurobindo Pharma USA, Inc. Each film-coated tablet contains 1.71g of varenicline tartrate equivalent to 1mg of varenicline free base. The dosage and usage instructions can be found in the accompanying prescribing information. The tablets should be stored in controlled room temperature conditions (56° to 86°F). The pharmacist is advised to dispense the medication guide separately to each patient. For more information, visit the Aurobindo Pharma USA, Inc. website.*
Structure (Varenicline Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
